Search results
Results from the WOW.Com Content Network
Subcutaneous implantable cardioverter defibrillator, or S-ICD, is an implantable medical device for detecting and terminating ventricular tachycardia and ventricular fibrillation in patients at risk of sudden cardiac arrest. [1]
Illustration of Implantable Cardioverter Defibrillator (ICD) An implantable cardioverter-defibrillator (ICD) or automated implantable cardioverter defibrillator (AICD) is a device implantable inside the body, able to perform defibrillation, and depending on the type, cardioversion and pacing of the heart.
The privately held company's focus was on a new generation of minimally invasive implantable cardioverter-defibrillator (ICD) which they called a Subcutaneous Implantable Defibrillator (S-ICD). Cameron Health's approach avoided implanting transvenous leads into the heart , which had been the usual procedure for cardiac devices.
Implantable cardioverter-defibrillators, also known as automatic internal cardiac defibrillator (AICD), are implants similar to pacemakers (and many can also perform the pacemaking function). They constantly monitor the patient's heart rhythm, and automatically administer shocks for various life-threatening arrhythmias, according to the device ...
Subcutaneous implantable defibrillator; T. T wave; Transcutaneous pacing; Transvenous pacing; U. U wave; V. Ventricular action potential This page was last edited ...
Subcutaneous implantable defibrillator; T. Transcatheter aortic valve replacement; Transcatheter pulmonary valve replacement; Transmyocardial revascularization; V.
Implantable cardioverter-defibrillator; Implantable loop recorder; In vitro models for calcification; ... Subcutaneous implantable defibrillator; Subdermal implant;
Neuromodulation is the second-oldest and third-largest department of Medtronic. Its products include neurostimulation systems and implantable drug delivery systems for chronic pain, common movement disorders, and urologic and gastrointestinal disorders. The department's revenues in 2014 amounted to $1.9 billion, or 11% of Medtronic's total ...